Visceral fat inflammation and fat embolism are associated with lung’s lipidic hyaline membranes in subjects with COVID-19
Background Preliminary data suggested that fat embolism could explain the importance of visceral obesity as a critical determinant of coronavirus disease-2019 (COVID-19). Methods We performed a comprehensive histomorphologic analysis of autoptic visceral adipose tissue (VAT), lungs and livers of 19...
Saved in:
Published in | International Journal of Obesity Vol. 46; no. 5; pp. 1009 - 1017 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
01.05.2022
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background
Preliminary data suggested that fat embolism could explain the importance of visceral obesity as a critical determinant of coronavirus disease-2019 (COVID-19).
Methods
We performed a comprehensive histomorphologic analysis of autoptic visceral adipose tissue (VAT), lungs and livers of 19 subjects with COVID-19 (COVID-19+), and 23 people without COVID-19 (controls). Human adipocytes (hMADS) infected with SARS-CoV-2 were also studied.
Results
Although there were no between-group differences in body-mass-index and adipocytes size, a higher prevalence of CD68+ macrophages among COVID-19+ VAT was detected (
p
= 0.005) and accompanied by crown-like structures presence, signs of adipocytes stress and death. Consistently, human adipocytes were successfully infected by SARS-CoV-2 in vitro and displayed lower cell viability. Being VAT inflammation associated with lipids spill-over from dead adipocytes, we studied lipids distribution by ORO. Lipids were observed within lungs and livers interstitial spaces, macrophages, endothelial cells, and vessels lumen, features suggestive of fat embolism syndrome, more prevalent among COVID-19+ (
p
< 0.001). Notably, signs of fat embolism were more prevalent among people with obesity (
p
= 0.03) independently of COVID-19 diagnosis, suggesting that such condition may be an obesity complication exacerbated by SARS-CoV-2 infection. Importantly, all infected subjects’ lungs presented lipids-rich (ORO+) hyaline membranes, formations associated with COVID-19-related pneumonia, present only in one control patient with non-COVID-19-related pneumonia. Importantly, transition aspects between embolic fat and hyaline membranes were also observed.
Conclusions
This study confirms the lung fat embolism in COVID-19+ patients and describes for the first time novel COVID-19-related features possibly underlying the unfavorable prognosis in people with COVID-19 and obesity. |
---|---|
AbstractList | Preliminary data suggested that fat embolism could explain the importance of visceral obesity as a critical determinant of coronavirus disease-2019 (COVID-19).
We performed a comprehensive histomorphologic analysis of autoptic visceral adipose tissue (VAT), lungs and livers of 19 subjects with COVID-19 (COVID-19+), and 23 people without COVID-19 (controls). Human adipocytes (hMADS) infected with SARS-CoV-2 were also studied.
Although there were no between-group differences in body-mass-index and adipocytes size, a higher prevalence of CD68+ macrophages among COVID-19+ VAT was detected (p = 0.005) and accompanied by crown-like structures presence, signs of adipocytes stress and death. Consistently, human adipocytes were successfully infected by SARS-CoV-2 in vitro and displayed lower cell viability. Being VAT inflammation associated with lipids spill-over from dead adipocytes, we studied lipids distribution by ORO. Lipids were observed within lungs and livers interstitial spaces, macrophages, endothelial cells, and vessels lumen, features suggestive of fat embolism syndrome, more prevalent among COVID-19+ (p < 0.001). Notably, signs of fat embolism were more prevalent among people with obesity (p = 0.03) independently of COVID-19 diagnosis, suggesting that such condition may be an obesity complication exacerbated by SARS-CoV-2 infection. Importantly, all infected subjects' lungs presented lipids-rich (ORO+) hyaline membranes, formations associated with COVID-19-related pneumonia, present only in one control patient with non-COVID-19-related pneumonia. Importantly, transition aspects between embolic fat and hyaline membranes were also observed.
This study confirms the lung fat embolism in COVID-19+ patients and describes for the first time novel COVID-19-related features possibly underlying the unfavorable prognosis in people with COVID-19 and obesity. BackgroundPreliminary data suggested that fat embolism could explain the importance of visceral obesity as a critical determinant of coronavirus disease-2019 (COVID-19).MethodsWe performed a comprehensive histomorphologic analysis of autoptic visceral adipose tissue (VAT), lungs and livers of 19 subjects with COVID-19 (COVID-19+), and 23 people without COVID-19 (controls). Human adipocytes (hMADS) infected with SARS-CoV-2 were also studied.ResultsAlthough there were no between-group differences in body-mass-index and adipocytes size, a higher prevalence of CD68+ macrophages among COVID-19+ VAT was detected (p = 0.005) and accompanied by crown-like structures presence, signs of adipocytes stress and death. Consistently, human adipocytes were successfully infected by SARS-CoV-2 in vitro and displayed lower cell viability. Being VAT inflammation associated with lipids spill-over from dead adipocytes, we studied lipids distribution by ORO. Lipids were observed within lungs and livers interstitial spaces, macrophages, endothelial cells, and vessels lumen, features suggestive of fat embolism syndrome, more prevalent among COVID-19+ (p < 0.001). Notably, signs of fat embolism were more prevalent among people with obesity (p = 0.03) independently of COVID-19 diagnosis, suggesting that such condition may be an obesity complication exacerbated by SARS-CoV-2 infection. Importantly, all infected subjects’ lungs presented lipids-rich (ORO+) hyaline membranes, formations associated with COVID-19-related pneumonia, present only in one control patient with non-COVID-19-related pneumonia. Importantly, transition aspects between embolic fat and hyaline membranes were also observed.ConclusionsThis study confirms the lung fat embolism in COVID-19+ patients and describes for the first time novel COVID-19-related features possibly underlying the unfavorable prognosis in people with COVID-19 and obesity. Preliminary data suggested that fat embolism could explain the importance of visceral obesity as a critical determinant of coronavirus disease-2019 (COVID-19).BACKGROUNDPreliminary data suggested that fat embolism could explain the importance of visceral obesity as a critical determinant of coronavirus disease-2019 (COVID-19).We performed a comprehensive histomorphologic analysis of autoptic visceral adipose tissue (VAT), lungs and livers of 19 subjects with COVID-19 (COVID-19+), and 23 people without COVID-19 (controls). Human adipocytes (hMADS) infected with SARS-CoV-2 were also studied.METHODSWe performed a comprehensive histomorphologic analysis of autoptic visceral adipose tissue (VAT), lungs and livers of 19 subjects with COVID-19 (COVID-19+), and 23 people without COVID-19 (controls). Human adipocytes (hMADS) infected with SARS-CoV-2 were also studied.Although there were no between-group differences in body-mass-index and adipocytes size, a higher prevalence of CD68+ macrophages among COVID-19+ VAT was detected (p = 0.005) and accompanied by crown-like structures presence, signs of adipocytes stress and death. Consistently, human adipocytes were successfully infected by SARS-CoV-2 in vitro and displayed lower cell viability. Being VAT inflammation associated with lipids spill-over from dead adipocytes, we studied lipids distribution by ORO. Lipids were observed within lungs and livers interstitial spaces, macrophages, endothelial cells, and vessels lumen, features suggestive of fat embolism syndrome, more prevalent among COVID-19+ (p < 0.001). Notably, signs of fat embolism were more prevalent among people with obesity (p = 0.03) independently of COVID-19 diagnosis, suggesting that such condition may be an obesity complication exacerbated by SARS-CoV-2 infection. Importantly, all infected subjects' lungs presented lipids-rich (ORO+) hyaline membranes, formations associated with COVID-19-related pneumonia, present only in one control patient with non-COVID-19-related pneumonia. Importantly, transition aspects between embolic fat and hyaline membranes were also observed.RESULTSAlthough there were no between-group differences in body-mass-index and adipocytes size, a higher prevalence of CD68+ macrophages among COVID-19+ VAT was detected (p = 0.005) and accompanied by crown-like structures presence, signs of adipocytes stress and death. Consistently, human adipocytes were successfully infected by SARS-CoV-2 in vitro and displayed lower cell viability. Being VAT inflammation associated with lipids spill-over from dead adipocytes, we studied lipids distribution by ORO. Lipids were observed within lungs and livers interstitial spaces, macrophages, endothelial cells, and vessels lumen, features suggestive of fat embolism syndrome, more prevalent among COVID-19+ (p < 0.001). Notably, signs of fat embolism were more prevalent among people with obesity (p = 0.03) independently of COVID-19 diagnosis, suggesting that such condition may be an obesity complication exacerbated by SARS-CoV-2 infection. Importantly, all infected subjects' lungs presented lipids-rich (ORO+) hyaline membranes, formations associated with COVID-19-related pneumonia, present only in one control patient with non-COVID-19-related pneumonia. Importantly, transition aspects between embolic fat and hyaline membranes were also observed.This study confirms the lung fat embolism in COVID-19+ patients and describes for the first time novel COVID-19-related features possibly underlying the unfavorable prognosis in people with COVID-19 and obesity.CONCLUSIONSThis study confirms the lung fat embolism in COVID-19+ patients and describes for the first time novel COVID-19-related features possibly underlying the unfavorable prognosis in people with COVID-19 and obesity. Background Preliminary data suggested that fat embolism could explain the importance of visceral obesity as a critical determinant of coronavirus disease-2019 (COVID-19). Methods We performed a comprehensive histomorphologic analysis of autoptic visceral adipose tissue (VAT), lungs and livers of 19 subjects with COVID-19 (COVID-19+), and 23 people without COVID-19 (controls). Human adipocytes (hMADS) infected with SARS-CoV-2 were also studied. Results Although there were no between-group differences in body-mass-index and adipocytes size, a higher prevalence of CD68+ macrophages among COVID-19+ VAT was detected ( p = 0.005) and accompanied by crown-like structures presence, signs of adipocytes stress and death. Consistently, human adipocytes were successfully infected by SARS-CoV-2 in vitro and displayed lower cell viability. Being VAT inflammation associated with lipids spill-over from dead adipocytes, we studied lipids distribution by ORO. Lipids were observed within lungs and livers interstitial spaces, macrophages, endothelial cells, and vessels lumen, features suggestive of fat embolism syndrome, more prevalent among COVID-19+ ( p < 0.001). Notably, signs of fat embolism were more prevalent among people with obesity ( p = 0.03) independently of COVID-19 diagnosis, suggesting that such condition may be an obesity complication exacerbated by SARS-CoV-2 infection. Importantly, all infected subjects’ lungs presented lipids-rich (ORO+) hyaline membranes, formations associated with COVID-19-related pneumonia, present only in one control patient with non-COVID-19-related pneumonia. Importantly, transition aspects between embolic fat and hyaline membranes were also observed. Conclusions This study confirms the lung fat embolism in COVID-19+ patients and describes for the first time novel COVID-19-related features possibly underlying the unfavorable prognosis in people with COVID-19 and obesity. |
Author | Tagliabracci, Adriano Perugini, Jessica Giordano, Antonio Ladoux, Annie Cinti, Saverio Caucci, Sara Bagnarelli, Patrizia Zingaretti, Cristina M. Graciotti, Laura Menzo, Stefano Di Vincenzo, Angelica Dani, Christian Nisoli, Enzo Di Mercurio, Eleonora Colleluori, Georgia Pesaresi, Mauro |
Author_xml | – sequence: 1 givenname: Georgia orcidid: 0000-0002-4908-9873 surname: Colleluori fullname: Colleluori, Georgia organization: Center for the Study of Obesity, Department of Experimental and Clinical Medicine, Marche Polytechnic University – sequence: 2 givenname: Laura surname: Graciotti fullname: Graciotti, Laura organization: Section of Experimental Pathology, Department of Clinical and Molecular Sciences, Marche Polytechnic University, Section of Microbiology, Department of Bioscience and Public Health, Marche Polytechnic University – sequence: 3 givenname: Mauro surname: Pesaresi fullname: Pesaresi, Mauro organization: Section of Legal Medicine, Department of Bioscience and Public Health, Marche Polytechnic University – sequence: 4 givenname: Angelica surname: Di Vincenzo fullname: Di Vincenzo, Angelica organization: Center for the Study of Obesity, Department of Experimental and Clinical Medicine, Marche Polytechnic University – sequence: 5 givenname: Jessica surname: Perugini fullname: Perugini, Jessica organization: Center for the Study of Obesity, Department of Experimental and Clinical Medicine, Marche Polytechnic University – sequence: 6 givenname: Eleonora surname: Di Mercurio fullname: Di Mercurio, Eleonora organization: Center for the Study of Obesity, Department of Experimental and Clinical Medicine, Marche Polytechnic University – sequence: 7 givenname: Sara surname: Caucci fullname: Caucci, Sara organization: Section of Microbiology, Department of Bioscience and Public Health, Marche Polytechnic University – sequence: 8 givenname: Patrizia surname: Bagnarelli fullname: Bagnarelli, Patrizia organization: Section of Microbiology, Department of Bioscience and Public Health, Marche Polytechnic University – sequence: 9 givenname: Cristina M. surname: Zingaretti fullname: Zingaretti, Cristina M. organization: Center for the Study of Obesity, Department of Experimental and Clinical Medicine, Marche Polytechnic University – sequence: 10 givenname: Enzo orcidid: 0000-0002-6670-1630 surname: Nisoli fullname: Nisoli, Enzo organization: Center for Study and Research on Obesity, Department of Medical Biotechnology and Translational Medicine, University of Milan – sequence: 11 givenname: Stefano surname: Menzo fullname: Menzo, Stefano organization: Section of Microbiology, Department of Bioscience and Public Health, Marche Polytechnic University – sequence: 12 givenname: Adriano surname: Tagliabracci fullname: Tagliabracci, Adriano organization: Section of Legal Medicine, Department of Bioscience and Public Health, Marche Polytechnic University – sequence: 13 givenname: Annie surname: Ladoux fullname: Ladoux, Annie organization: Université Côte d’Azur, CNRS, Inserm, iBV, Faculté de Médecine – sequence: 14 givenname: Christian surname: Dani fullname: Dani, Christian organization: Université Côte d’Azur, CNRS, Inserm, iBV, Faculté de Médecine – sequence: 15 givenname: Antonio surname: Giordano fullname: Giordano, Antonio organization: Center for the Study of Obesity, Department of Experimental and Clinical Medicine, Marche Polytechnic University – sequence: 16 givenname: Saverio orcidid: 0000-0003-0362-5017 surname: Cinti fullname: Cinti, Saverio email: cinti@univpm.it organization: Center for the Study of Obesity, Department of Experimental and Clinical Medicine, Marche Polytechnic University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35082385$$D View this record in MEDLINE/PubMed |
BookMark | eNp9Us1u1DAYtFAR3RZegAOyxIVLwL-xc0FCS4FKlXqBXi3HcXa9cuzFTrqquPAafT2eBO-m5aeHnmzZM-MZf3MCjkIMFoCXGL3FiMp3mWFa1xUipEIYCVztnoAFZqKuOGvEEVggikSFeM2PwUnOG4QQ54g8A8eUI0mo5Avw48plY5P2sNcjdKH3ehj06GKAOnSHQzu00bs8QJ0s1DlH4_RoO7hz4xr6Kax-_bzN0Lut65yB6xvtXbBwKLSkg81FFOap3Vgz5pmzvLw6_1jh5jl42muf7Yu79RR8-3T2dfmlurj8fL78cFEZJthYtZxKaUlb97y3DSGm1roRzHZM21ZQ3uqyaRDqDBGEamGwQD2T1vQaEyEwPQXvZ93t1A62MzaMJbDaJjfodKOidur_m-DWahWvlRRFFski8OZOIMXvk82jGva_5n3JF6esSE0oJbzB-7deP4Bu4pRCiVdQvGaMSMQK6tW_jv5YuZ9LAcgZYFLMOdleGTcexlIMOq8wUvsKqLkCqlRAHSqgdoVKHlDv1R8l0ZmUCzisbPpr-xHWb3ABxss |
CitedBy_id | crossref_primary_10_3390_diseases12050097 crossref_primary_10_3390_nu14173493 crossref_primary_10_1038_s41467_024_48055_0 crossref_primary_10_1055_a_1878_9757 crossref_primary_10_1186_s12879_023_08559_4 crossref_primary_10_3390_ijms23137349 crossref_primary_10_3389_fimmu_2023_1083191 crossref_primary_10_3390_ijms25042086 crossref_primary_10_1007_s11357_023_01058_z crossref_primary_10_22141_2307_1257_12_1_2023_393 crossref_primary_10_1016_j_beem_2023_101761 crossref_primary_10_1038_s41467_022_33218_8 crossref_primary_10_5507_bp_2024_014 crossref_primary_10_1111_trf_17220 crossref_primary_10_1038_s41419_023_05574_w crossref_primary_10_2147_JIR_S477526 crossref_primary_10_3390_cells11132109 crossref_primary_10_3389_fbinf_2023_1163430 crossref_primary_10_11603_1681_2786_2023_1_13539 crossref_primary_10_3389_fendo_2022_1122274 crossref_primary_10_46847_ujmm_2023_2_4__078 crossref_primary_10_3390_ijms232314898 crossref_primary_10_1016_j_isci_2025_111837 crossref_primary_10_1016_j_tem_2023_08_010 |
Cites_doi | 10.1016/S2213-2600(20)30076-X 10.1097/PAF.0000000000000544 10.15585/mmwr.mm7010e4 10.1023/B:NEUR.0000011328.61376.bb 10.2337/dc20-1333 10.3389/fendo.2021.652765 10.1038/nature21363 10.1371/journal.pone.0254872 10.1097/ALN.0000000000001334 10.1126/science.368.6489.356 10.3201/eid1002.030913 10.1016/S0140-6736(20)31305-2 10.1002/oby.23007 10.1152/ajpregu.00183.2008 10.1194/jlr.M800019-JLR200 10.1016/j.cell.2021.03.005 10.1194/jlr.M500294-JLR200 10.5603/ARM.a2021.0036 10.1038/s41366-021-01016-9 10.1016/j.metabol.2020.154319 10.15252/msb.20209610 10.1038/s41366-020-00670-9 10.1101/2021.10.30.466586 10.1038/s41598-017-08444-6 10.1016/j.cmet.2021.01.016 10.3389/fimmu.2020.00392 10.1099/vir.0.052910-0 10.1126/science.abd2985 10.1016/S0140-6736(20)30183-5 10.1038/s41586-020-2521-4 10.1038/s41379-020-00649-x 10.2337/db20-1094 10.1016/j.biochi.2004.11.007 10.1038/nrmicro2147 10.1038/nature14177 10.1016/j.metabol.2020.154317 10.1194/jlr.M038638 10.1128/mSphere.00647-21 10.1111/his.14180 10.1016/j.cmet.2021.09.009 10.3390/genes11080929 10.1038/s41366-020-0624-5 10.1002/0471141755.ph1208s25 10.1038/s41574-020-00462-1 10.1016/j.exger.2021.111561 10.1016/j.celrep.2021.109364 10.1161/JAHA.120.019259 |
ContentType | Journal Article |
Copyright | The Author(s), under exclusive licence to Springer Nature Limited 2022 2022. The Author(s), under exclusive licence to Springer Nature Limited. The Author(s), under exclusive licence to Springer Nature Limited 2022. |
Copyright_xml | – notice: The Author(s), under exclusive licence to Springer Nature Limited 2022 – notice: 2022. The Author(s), under exclusive licence to Springer Nature Limited. – notice: The Author(s), under exclusive licence to Springer Nature Limited 2022. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7T2 7TK 7TS 7X2 7X7 7XB 88E 88G 8AO 8C1 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA ATCPS AZQEC BBNVY BENPR BHPHI C1K CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0K M0S M1P M2M M7P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PSYQQ Q9U 7X8 5PM |
DOI | 10.1038/s41366-022-01071-w |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health and Safety Science Abstracts (Full archive) Neurosciences Abstracts Physical Education Index Agricultural Science Collection Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest Pharma Collection Public Health Database ProQuest SciTech Collection ProQuest Natural Science Journals Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland Agricultural & Environmental Science Collection ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One ProQuest Central Korea Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences Agricultural Science Database ProQuest Health & Medical Collection Medical Database Psychology Database Biological Science Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database ProQuest One Psychology ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China Physical Education Index Environmental Sciences and Pollution Management ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Agricultural & Environmental Science Collection Biological Science Collection Health & Safety Science Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest Biological Science Collection ProQuest Central Basic ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE Agricultural Science Database MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Public Health Diet & Clinical Nutrition Recreation & Sports |
EISSN | 1476-5497 |
EndPage | 1017 |
ExternalDocumentID | PMC8790008 35082385 10_1038_s41366_022_01071_w |
Genre | Journal Article |
GroupedDBID | .55 .GJ 29J 36B 39C 5RE 7X2 7X7 8R4 8R5 A8Z ABDBF ABOCM ABUWG ACUHS ADBBV AFFNX AI. ALMA_UNASSIGNED_HOLDINGS ATCPS AZQEC B0M BAWUL BENPR BHPHI BPHCQ DIK DWQXO EAD EAP EBC EBD EBS EMB EMK EMOBN EPL ESX F5P FYUFA GNUQQ HCIFZ IAO IHR ITC J5H M0K M1P M2M MVM NAO OK1 Q2X RNT RNTTT SV3 TUS VH1 WH7 X7M ZGI ZXP ~8M AAYXX CITATION --- -Q- ..I .L3 .XZ 0R~ 1CY 2FS 2WC 3V. 4.4 406 53G 5GY 70F 88E 8AO 8C1 8FE 8FH 8FI 8FJ AACDK AAHBH AANZL AASML AATNV AAWTL AAYZH AAZLF ABAKF ABAWZ ABCQX ABIVO ABJNI ABLJU ABZZP ACAOD ACGFS ACKTT ACPRK ACRQY ACZOJ ADHDB ADHUB AEFQL AEJRE AEMSY AENEX AEUYN AEVLU AEXYK AFBBN AFKRA AFRAH AFSHS AGAYW AGHAI AGQEE AHMBA AHSBF AIGIU AILAN AJRNO ALFFA ALIPV AMYLF APEBS AXYYD BBNVY BKKNO BVXVI CCPQU CGR CS3 CUY CVF DNIVK DPUIP DU5 E3Z EBLON ECM EE. EIF EIOEI EJD FDQFY FERAY FIGPU FIZPM FSGXE HMCUK HZ~ IHW INH INR IPY IWAJR JSO JZLTJ KQ8 L7B M7P NPM NQJWS O9- OVD P2P P6G PKN PQQKQ PROAC PSQYO PSYQQ RNS ROL SNX SNYQT SOHCF SOJ SRMVM SWTZT TAOOD TBHMF TDRGL TEORI TR2 TSG UKHRP YCJ ~KM 7T2 7TK 7TS 7XB 8FK C1K K9. LK8 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS Q9U 7X8 ABBRH ABDBE ABFSG ACSTC AEZWR AFDZB AFHIU AHWEU AIXLP ATHPR AYFIA 5PM |
ID | FETCH-LOGICAL-c474t-b5388e2b6f5fe922c6aa974ed4aeb735ba4ae900dc2723a7c170f48ecfa127713 |
IEDL.DBID | 7X7 |
ISSN | 0307-0565 1476-5497 |
IngestDate | Thu Aug 21 14:10:49 EDT 2025 Fri Jul 11 11:18:01 EDT 2025 Sat Aug 23 12:22:30 EDT 2025 Wed Feb 19 02:25:52 EST 2025 Thu Apr 24 23:06:32 EDT 2025 Tue Jul 01 03:02:04 EDT 2025 Fri Feb 21 02:39:35 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Language | English |
License | 2022. The Author(s), under exclusive licence to Springer Nature Limited. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c474t-b5388e2b6f5fe922c6aa974ed4aeb735ba4ae900dc2723a7c170f48ecfa127713 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-4908-9873 0000-0002-6670-1630 0000-0003-0362-5017 |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC8790008 |
PMID | 35082385 |
PQID | 2656442804 |
PQPubID | 38864 |
PageCount | 9 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_8790008 proquest_miscellaneous_2623325911 proquest_journals_2656442804 pubmed_primary_35082385 crossref_citationtrail_10_1038_s41366_022_01071_w crossref_primary_10_1038_s41366_022_01071_w springer_journals_10_1038_s41366_022_01071_w |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-05-01 |
PublicationDateYYYYMMDD | 2022-05-01 |
PublicationDate_xml | – month: 05 year: 2022 text: 2022-05-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | International Journal of Obesity |
PublicationTitleAbbrev | Int J Obes |
PublicationTitleAlternate | Int J Obes (Lond) |
PublicationYear | 2022 |
Publisher | Nature Publishing Group UK Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
References | O’HearnMLiuJCudheaFMichaRMozaffarianDCoronavirus Disease 2019 hospitalizations attributable to cardiometabolic conditions in the United States: a comparative risk assessment analysisJ Am Heart Assoc202110e01925933629868817424410.1161/JAHA.120.019259 Shin J, Toyoda S, Nishitani S, Fukuhara A, Kita S, Otsuki M, et al. Possible involvement of adipose tissue in patients with older age, obesity, and diabetes with Coronavirus SARS-CoV-2 infection (COVID-19) via GRP78 (BIP/HSPA5): significance of hyperinsulinemia management in COVID-19. Diabetes. 2021;70:2745–2755. Puray-ChavezMLaPakKMSchrankTPElliottJLBhattDPAgajanianMJSystematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cellCell Rep2021361093641:CAS:528:DC%2BB3MXhsVKltrjP34214467822094510.1016/j.celrep.2021.109364 GanesanSKVenkatratnamPMahendraJDevarajanNIncreased mortality of COVID-19 infected diabetes patients: role of furin proteasesInt J Obes202044248681:CAS:528:DC%2BB3cXhslOgsbjI10.1038/s41366-020-00670-9 PetersenABressemKAlbrechtJThiessHMVahldiekJHammBThe role of visceral adiposity in the severity of COVID-19: Highlights from a unicenter cross-sectional pilot study in GermanyMetabolism.20201101543171:CAS:528:DC%2BB3cXhsVOqsb3M32673651735817610.1016/j.metabol.2020.154317 HikmetFMearLEdvinssonAMickePUhlenMLindskogCThe protein expression profile of ACE2 in human tissuesMol Syst Biol202016e96101:CAS:528:DC%2BB3cXhsFWqurrK32715618738309110.15252/msb.20209610 Colleluori G, Graciotti L, Pesaresi M, Di Vincenzo A, Perugini J, Di Mercurio E, et al. Visceral fat inflammation and fat embolism are associated with lung’s lipidic hyaline membranes in COVID-19 patients. bioRxiv. 2021. https://doi.org/10.1101/2021.10.30.466586. HirschbuhlKDintnerSBeerMWylezichCSchlegelJDelbridgeCViral mapping in COVID-19 deceased in the Augsburg autopsy series of the first wave: a multiorgan and multimethodological approachPLoS ONE202116e025487234280238828911010.1371/journal.pone.02548721:CAS:528:DC%2BB3MXhs1ehsr7I BattistiSPedoneCNapoliNRussoEAgnolettiVNigraSGComputed tomography highlights increased visceral adiposity associated with critical illness in COVID-19Diabetes Care202043e129301:CAS:528:DC%2BB3cXit1ymt7jL3275345710.2337/dc20-1333 GiordanoACesariPCapparucciaLCastellucciMCintiSSema3A and neuropilin-1 expression and distribution in rat white adipose tissueJ Neurocytol200332345521:CAS:528:DC%2BD2cXisVehtg%3D%3D1472437710.1023/B:NEUR.0000011328.61376.bb MuranoIBarbatelliGParisaniVLatiniCMuzzonigroGCastellucciMDead adipocytes, detected as crown-like structures, are prevalent in visceral fat depots of genetically obese miceJ Lipid Res200849156281:CAS:528:DC%2BD1cXotVOqu7Y%3D1839048710.1194/jlr.M800019-JLR200 RodriguezAMElabdCAmriEZAilhaudGDaniCThe human adipose tissue is a source of multipotent stem cellsBiochimie.20058712581:CAS:528:DC%2BD2MXhslCntb4%3D1573374710.1016/j.biochi.2004.11.007 Cantuti-CastelvetriLOjhaRPedroLDDjannatianMFranzJKuivanenSNeuropilin-1 facilitates SARS-CoV-2 cell entry and infectivityScience.2020370856601:CAS:528:DC%2BB3cXitlCmt7rF33082293785739110.1126/science.abd2985 Cummings BS, Schnellmann RG. Measurement of cell death in mammalian cells. Curr Protoc Pharmacol. 2004. Alessandrini F, Caucci S, Onofri V, Melchionda F, Tagliabracci A, Bagnarelli P, et al. Evaluation of the ion AmpliSeq SARS-CoV-2 research panel by massive parallel sequencing. Genes. 2020;11:929–941. Medicine JHU. Coronavirus resource center. 2021. https://coronavirus.jhu.edu/map.html. MengYZhangMLingHHuangSMiaoQYuYNontraumatic multiple-organ fat embolism: an autopsy case and review of literatureAm J Forensic Med Pathol20204113143237909610.1097/PAF.0000000000000544 Frasca D, Reidy L, Romero M, Diaz A, Cray C, Kahl K, et al. The majority of SARS-CoV-2-specific antibodies in COVID-19 patients with obesity are autoimmune and not neutralizing. Int J Obes. 2021;1–6. https://doi.org/10.1038/s41366-021-01016-9. WilliamsonEJWalkerAJBhaskaranKBaconSBatesCMortonCEFactors associated with COVID-19-related death using OpenSAFELYNature.202058443061:CAS:528:DC%2BB3cXhsFegtbzK32640463761107410.1038/s41586-020-2521-4 SchneiderJLRoweJHGarcia-de-AlbaCKimCFSharpeAHHaigisMCThe aging lung: physiology, disease, and immunityCell.2021184199020191:CAS:528:DC%2BB3MXot1GitLk%3D33811810805229510.1016/j.cell.2021.03.005 de WildeAHRajVSOudshoornDBestebroerTMvan NieuwkoopSLimpensRMERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-alpha treatmentJ Gen Virol20139417496023620378374952310.1099/vir.0.052910-01:CAS:528:DC%2BC3sXht12gs7rI HotamisligilGSInflammation, metaflammation and immunometabolic disordersNature.2017542177851:CAS:528:DC%2BC2sXitlGitbk%3D2817965610.1038/nature21363 Ghadially F. Ultrastructural pathology of the cell and matrix. 1997 (Butterworth-Heinemann, Boston). WadmanMCouzin-FrankelJKaiserJMatacicCA rampage through the bodyScience.2020368356601:CAS:528:DC%2BB3cXnslKrtro%3D3232758010.1126/science.368.6489.356 StefanNBirkenfeldALSchulzeMBGlobal pandemics interconnected—obesity, impaired metabolic health and COVID-19Nat Rev Endocrinol202117135491:CAS:528:DC%2BB3MXit1yqt7o%3D3347953810.1038/s41574-020-00462-1 MorysFDagherAPoor metabolic health increases COVID-19-related mortality in the UK biobank sampleFront Endocrinol20211265276510.3389/fendo.2021.652765 BradleyBTMaioliHJohnstonRChaudhryIFinkSLXuHHistopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case seriesLancet.2020396320321:CAS:528:DC%2BB3cXhsVWgs7jL32682491736565010.1016/S0140-6736(20)31305-2 LockeAEKahaliBBerndtSIJusticeAEPersTHDayFRGenetic studies of body mass index yield new insights for obesity biologyNature.20155181972061:CAS:528:DC%2BC2MXislehtL8%3D25673413438221110.1038/nature14177 CintiSZingarettiMCCancelloRCeresiEFerraraPMorphologic techniques for the study of brown adipose tissue and white adipose tissueMethods Mol Biol200115521511:STN:280:DC%2BD3MrlvVyrtg%3D%3D11293073 CintiSGraciottiLGiordanoAValerioANisoliECOVID-19 and fat embolism: a hypothesis to explain the severe clinical outcome in people with obesityInt J Obes.202044180021:CAS:528:DC%2BB3cXhtFCnt7jI10.1038/s41366-020-0624-5 CamastraSVitaliAAnselminoMGastaldelliABelliniRBertaRMuscle and adipose tissue morphology, insulin sensitivity and beta-cell function in diabetic and nondiabetic obese patients: effects of bariatric surgerySci Rep2017728827671556642910.1038/s41598-017-08444-61:CAS:528:DC%2BC1cXhtlyhsr%2FP FrascaDDiazARomeroMGarciaDJayramDThallerSIdentification and characterization of adipose tissue-derived human antibodies with “Anti-self” specificityFront Immunol2020113921:CAS:528:DC%2BB3cXhsVGitbvL32184790705899710.3389/fimmu.2020.00392 WatanabeMCarusoDTuccinardiDRisiRZerunianMPoliciMVisceral fat shows the strongest association with the need of intensive care in patients with COVID-19Metabolism.20201111543191:CAS:528:DC%2BB3cXhs12rur3P32712222737778810.1016/j.metabol.2020.154319 HuangCWangYLiXRenLZhaoJHuYClinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaLancet.20203954975061:CAS:528:DC%2BB3cXhs1Kqu7c%3D31986264715929910.1016/S0140-6736(20)30183-5 OnderGPalmieriLVanacoreNGiulianoMBrusaferroSItalian National Institute of Health C-MG.Nonrespiratory complications and obesity in patients dying with COVID-19 in ItalyObesity2021292031:CAS:528:DC%2BB3MXlvFChug%3D%3D3281238310.1002/oby.23007 AlexaALOnutuAHFat embolism syndrome mimicking a COVID-19 infectionCase Rep Crit Care202120215519812340554198114880 RagotteRJPulidoDDonnellanFRHillMLGoriniGDaviesHHuman basigin (CD147) does not directly interact with SARS-CoV-2 spike glycoproteinmSphere.20216e00647213437898210.1128/mSphere.00647-21 WellmanTJde ProstNTucciMWinklerTBaronRMFilipczakPLung metabolic activation as an early biomarker of acute respiratory distress syndrome and local gene expression heterogeneityAnesthesiology.201612599210041:CAS:528:DC%2BC28XhslWjsbzI2761118510.1097/ALN.0000000000001334 LaganaSMKudoseSIugaACLeeMJFazlollahiLRemottiHEHepatic pathology in patients dying of COVID-19: a series of 40 cases including clinical, histologic, and virologic dataMod Pathol2020332147551:CAS:528:DC%2BB3cXhs1aitbbJ32792598742424510.1038/s41379-020-00649-x CintiSMitchellGBarbatelliGMuranoICeresiEFaloiaEAdipocyte death defines macrophage localization and function in adipose tissue of obese mice and humansJ Lipid Res2005462347551:CAS:528:DC%2BD2MXhtF2iu7vF1615082010.1194/jlr.M500294-JLR200 MahendraMNuchinAKumarRShreedharSMaheshPAPredictors of mortality in patients with severe COVID-19 pneumonia—a retrospective studyAdv Respir Med202189135441:STN:280:DC%2BB2c%2FitFaqtQ%3D%3D3396626110.5603/ARM.a2021.0036 GiordanoAMuranoIMondiniEPeruginiJSmorlesiASeveriIObese adipocytes show ultrastructural features of stressed cells and die of pyroptosisJ Lipid Res2013542423361:CAS:528:DC%2BC3sXht1aqsLnK23836106373594010.1194/jlr.M038638 ColleluoriGVillarealDTAging, obesity, sarcopenia and the effect of diet and exercise interventionExp Gerontol20211551115613456256810.1016/j.exger.2021.111561 ReitererMRajanMGomez-BanoyNLauJDGomez-EscobarLGMaLHyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2Cell Metab202133217488 e51:CAS:528:DC%2BB3MXitFCrs7jM34599884844333510.1016/j.cmet.2021.09.009 XuZShiLWangYZhangJHuangLZhangCPathological findings of COVID-19 associated with acute respiratory distress syndromeLancet Respir Med2020842021:CAS:528:DC%2BB3cXjsValtbk%3D32085846716477110.1016/S2213-2600(20)30076-X DruckerDJDiabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginningCell Metab202133479981:CAS:528:DC%2BB3MXivVanu7g%3D33529600782598210.1016/j.cmet.2021.01.016 KompaniyetsLGoodmanABBelayBFreedmanDSSucoskyMSLangeSJBody mass index and risk for COVID-19-related hospitalization, intensive care unit admission, invasive mechanical ventilation, and death—United States, March-December 2020Morb Mortal Wkly Rep.202170355611:CAS:528:DC%2BB3MXntlalsrY%3D10.15585/mmwr.mm7010e4 Perl S Cinti (1071_CR19) 2005; 46 G Onder (1071_CR11) 2021; 29 K Hirschbuhl (1071_CR28) 2021; 16 JL Schneider (1071_CR7) 2021; 184 GS Hotamisligil (1071_CR20) 2017; 542 I Murano (1071_CR25) 2008; 49 G Colleluori (1071_CR21) 2021; 155 1071_CR31 L Cantuti-Castelvetri (1071_CR39) 2020; 370 M Mahendra (1071_CR2) 2021; 89 1071_CR36 AL Alexa (1071_CR45) 2021; 2021 M Puray-Chavez (1071_CR37) 2021; 36 BT Bradley (1071_CR6) 2020; 396 AE Locke (1071_CR12) 2015; 518 SK Ganesan (1071_CR41) 2020; 44 EJ Williamson (1071_CR10) 2020; 584 A Petersen (1071_CR15) 2020; 110 S Cinti (1071_CR23) 2020; 44 SM Lagana (1071_CR34) 2020; 33 L Kompaniyets (1071_CR17) 2021; 70 1071_CR46 F Morys (1071_CR18) 2021; 12 1071_CR49 M O’Hearn (1071_CR9) 2021; 10 TJ Wellman (1071_CR44) 2016; 125 KE Konopka (1071_CR43) 2020; 77 S Cinti (1071_CR47) 2001; 155 D Frasca (1071_CR35) 2020; 11 AM Rodriguez (1071_CR50) 2005; 87 M Gupte (1071_CR22) 2008; 295 A Giordano (1071_CR32) 2013; 54 N Stefan (1071_CR8) 2021; 17 S Perlman (1071_CR33) 2009; 7 C Huang (1071_CR3) 2020; 395 Z Xu (1071_CR5) 2020; 8 1071_CR51 1071_CR52 AH de Wilde (1071_CR48) 2013; 94 M Wadman (1071_CR4) 2020; 368 F Hikmet (1071_CR38) 2020; 16 CS Goldsmith (1071_CR30) 2004; 10 Y Meng (1071_CR27) 2020; 41 1071_CR1 S Battisti (1071_CR13) 2020; 43 DJ Drucker (1071_CR16) 2021; 33 RJ Ragotte (1071_CR42) 2021; 6 M Reiterer (1071_CR29) 2021; 33 1071_CR24 M Watanabe (1071_CR14) 2020; 111 S Camastra (1071_CR26) 2017; 7 A Giordano (1071_CR40) 2003; 32 |
References_xml | – reference: HuangCWangYLiXRenLZhaoJHuYClinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaLancet.20203954975061:CAS:528:DC%2BB3cXhs1Kqu7c%3D31986264715929910.1016/S0140-6736(20)30183-5 – reference: CintiSMitchellGBarbatelliGMuranoICeresiEFaloiaEAdipocyte death defines macrophage localization and function in adipose tissue of obese mice and humansJ Lipid Res2005462347551:CAS:528:DC%2BD2MXhtF2iu7vF1615082010.1194/jlr.M500294-JLR200 – reference: DruckerDJDiabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginningCell Metab202133479981:CAS:528:DC%2BB3MXivVanu7g%3D33529600782598210.1016/j.cmet.2021.01.016 – reference: GupteMBoustany-KariCMBharadwajKPoliceSThatcherSGongMCACE2 is expressed in mouse adipocytes and regulated by a high-fat dietAm J Physiol Regul Integr Comp Physiol2008295R78181:CAS:528:DC%2BD1cXhtFCgtL3O18650320253686410.1152/ajpregu.00183.2008 – reference: HikmetFMearLEdvinssonAMickePUhlenMLindskogCThe protein expression profile of ACE2 in human tissuesMol Syst Biol202016e96101:CAS:528:DC%2BB3cXhsFWqurrK32715618738309110.15252/msb.20209610 – reference: SchneiderJLRoweJHGarcia-de-AlbaCKimCFSharpeAHHaigisMCThe aging lung: physiology, disease, and immunityCell.2021184199020191:CAS:528:DC%2BB3MXot1GitLk%3D33811810805229510.1016/j.cell.2021.03.005 – reference: GiordanoAMuranoIMondiniEPeruginiJSmorlesiASeveriIObese adipocytes show ultrastructural features of stressed cells and die of pyroptosisJ Lipid Res2013542423361:CAS:528:DC%2BC3sXht1aqsLnK23836106373594010.1194/jlr.M038638 – reference: HotamisligilGSInflammation, metaflammation and immunometabolic disordersNature.2017542177851:CAS:528:DC%2BC2sXitlGitbk%3D2817965610.1038/nature21363 – reference: KonopkaKENguyenTJentzenJMRayesOSchmidtCJWilsonAMDiffuse alveolar damage (DAD) resulting from coronavirus disease 2019 Infection is Morphologically Indistinguishable from Other Causes of DADHistopathology.20207757083254274310.1111/his.14180 – reference: PerlmanSNetlandJCoronaviruses post-SARS: update on replication and pathogenesisNat Rev Microbiol20097439501:CAS:528:DC%2BD1MXls1Cmt7k%3D19430490283009510.1038/nrmicro2147 – reference: LaganaSMKudoseSIugaACLeeMJFazlollahiLRemottiHEHepatic pathology in patients dying of COVID-19: a series of 40 cases including clinical, histologic, and virologic dataMod Pathol2020332147551:CAS:528:DC%2BB3cXhs1aitbbJ32792598742424510.1038/s41379-020-00649-x – reference: OnderGPalmieriLVanacoreNGiulianoMBrusaferroSItalian National Institute of Health C-MG.Nonrespiratory complications and obesity in patients dying with COVID-19 in ItalyObesity2021292031:CAS:528:DC%2BB3MXlvFChug%3D%3D3281238310.1002/oby.23007 – reference: GanesanSKVenkatratnamPMahendraJDevarajanNIncreased mortality of COVID-19 infected diabetes patients: role of furin proteasesInt J Obes202044248681:CAS:528:DC%2BB3cXhslOgsbjI10.1038/s41366-020-00670-9 – reference: MorysFDagherAPoor metabolic health increases COVID-19-related mortality in the UK biobank sampleFront Endocrinol20211265276510.3389/fendo.2021.652765 – reference: Frasca D, Reidy L, Romero M, Diaz A, Cray C, Kahl K, et al. The majority of SARS-CoV-2-specific antibodies in COVID-19 patients with obesity are autoimmune and not neutralizing. Int J Obes. 2021;1–6. https://doi.org/10.1038/s41366-021-01016-9. – reference: XuZShiLWangYZhangJHuangLZhangCPathological findings of COVID-19 associated with acute respiratory distress syndromeLancet Respir Med2020842021:CAS:528:DC%2BB3cXjsValtbk%3D32085846716477110.1016/S2213-2600(20)30076-X – reference: CintiSGraciottiLGiordanoAValerioANisoliECOVID-19 and fat embolism: a hypothesis to explain the severe clinical outcome in people with obesityInt J Obes.202044180021:CAS:528:DC%2BB3cXhtFCnt7jI10.1038/s41366-020-0624-5 – reference: RodriguezAMElabdCAmriEZAilhaudGDaniCThe human adipose tissue is a source of multipotent stem cellsBiochimie.20058712581:CAS:528:DC%2BD2MXhslCntb4%3D1573374710.1016/j.biochi.2004.11.007 – reference: BattistiSPedoneCNapoliNRussoEAgnolettiVNigraSGComputed tomography highlights increased visceral adiposity associated with critical illness in COVID-19Diabetes Care202043e129301:CAS:528:DC%2BB3cXit1ymt7jL3275345710.2337/dc20-1333 – reference: WellmanTJde ProstNTucciMWinklerTBaronRMFilipczakPLung metabolic activation as an early biomarker of acute respiratory distress syndrome and local gene expression heterogeneityAnesthesiology.201612599210041:CAS:528:DC%2BC28XhslWjsbzI2761118510.1097/ALN.0000000000001334 – reference: Ghadially F. Ultrastructural pathology of the cell and matrix. 1997 (Butterworth-Heinemann, Boston). – reference: Cummings BS, Schnellmann RG. Measurement of cell death in mammalian cells. Curr Protoc Pharmacol. 2004. – reference: Shin J, Toyoda S, Nishitani S, Fukuhara A, Kita S, Otsuki M, et al. Possible involvement of adipose tissue in patients with older age, obesity, and diabetes with Coronavirus SARS-CoV-2 infection (COVID-19) via GRP78 (BIP/HSPA5): significance of hyperinsulinemia management in COVID-19. Diabetes. 2021;70:2745–2755. – reference: AlexaALOnutuAHFat embolism syndrome mimicking a COVID-19 infectionCase Rep Crit Care202120215519812340554198114880 – reference: de WildeAHRajVSOudshoornDBestebroerTMvan NieuwkoopSLimpensRMERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-alpha treatmentJ Gen Virol20139417496023620378374952310.1099/vir.0.052910-01:CAS:528:DC%2BC3sXht12gs7rI – reference: KompaniyetsLGoodmanABBelayBFreedmanDSSucoskyMSLangeSJBody mass index and risk for COVID-19-related hospitalization, intensive care unit admission, invasive mechanical ventilation, and death—United States, March-December 2020Morb Mortal Wkly Rep.202170355611:CAS:528:DC%2BB3MXntlalsrY%3D10.15585/mmwr.mm7010e4 – reference: Puray-ChavezMLaPakKMSchrankTPElliottJLBhattDPAgajanianMJSystematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cellCell Rep2021361093641:CAS:528:DC%2BB3MXhsVKltrjP34214467822094510.1016/j.celrep.2021.109364 – reference: RagotteRJPulidoDDonnellanFRHillMLGoriniGDaviesHHuman basigin (CD147) does not directly interact with SARS-CoV-2 spike glycoproteinmSphere.20216e00647213437898210.1128/mSphere.00647-21 – reference: PetersenABressemKAlbrechtJThiessHMVahldiekJHammBThe role of visceral adiposity in the severity of COVID-19: Highlights from a unicenter cross-sectional pilot study in GermanyMetabolism.20201101543171:CAS:528:DC%2BB3cXhsVOqsb3M32673651735817610.1016/j.metabol.2020.154317 – reference: ColleluoriGVillarealDTAging, obesity, sarcopenia and the effect of diet and exercise interventionExp Gerontol20211551115613456256810.1016/j.exger.2021.111561 – reference: ISS. Istituto Superiore di Sanità-Research ethics during the COVID-19 pandemic: observational and, in particular, epidemiological studies. 2020. – reference: MengYZhangMLingHHuangSMiaoQYuYNontraumatic multiple-organ fat embolism: an autopsy case and review of literatureAm J Forensic Med Pathol20204113143237909610.1097/PAF.0000000000000544 – reference: BradleyBTMaioliHJohnstonRChaudhryIFinkSLXuHHistopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case seriesLancet.2020396320321:CAS:528:DC%2BB3cXhsVWgs7jL32682491736565010.1016/S0140-6736(20)31305-2 – reference: MahendraMNuchinAKumarRShreedharSMaheshPAPredictors of mortality in patients with severe COVID-19 pneumonia—a retrospective studyAdv Respir Med202189135441:STN:280:DC%2BB2c%2FitFaqtQ%3D%3D3396626110.5603/ARM.a2021.0036 – reference: WatanabeMCarusoDTuccinardiDRisiRZerunianMPoliciMVisceral fat shows the strongest association with the need of intensive care in patients with COVID-19Metabolism.20201111543191:CAS:528:DC%2BB3cXhs12rur3P32712222737778810.1016/j.metabol.2020.154319 – reference: O’HearnMLiuJCudheaFMichaRMozaffarianDCoronavirus Disease 2019 hospitalizations attributable to cardiometabolic conditions in the United States: a comparative risk assessment analysisJ Am Heart Assoc202110e01925933629868817424410.1161/JAHA.120.019259 – reference: CamastraSVitaliAAnselminoMGastaldelliABelliniRBertaRMuscle and adipose tissue morphology, insulin sensitivity and beta-cell function in diabetic and nondiabetic obese patients: effects of bariatric surgerySci Rep2017728827671556642910.1038/s41598-017-08444-61:CAS:528:DC%2BC1cXhtlyhsr%2FP – reference: WadmanMCouzin-FrankelJKaiserJMatacicCA rampage through the bodyScience.2020368356601:CAS:528:DC%2BB3cXnslKrtro%3D3232758010.1126/science.368.6489.356 – reference: HirschbuhlKDintnerSBeerMWylezichCSchlegelJDelbridgeCViral mapping in COVID-19 deceased in the Augsburg autopsy series of the first wave: a multiorgan and multimethodological approachPLoS ONE202116e025487234280238828911010.1371/journal.pone.02548721:CAS:528:DC%2BB3MXhs1ehsr7I – reference: FrascaDDiazARomeroMGarciaDJayramDThallerSIdentification and characterization of adipose tissue-derived human antibodies with “Anti-self” specificityFront Immunol2020113921:CAS:528:DC%2BB3cXhsVGitbvL32184790705899710.3389/fimmu.2020.00392 – reference: Medicine JHU. Coronavirus resource center. 2021. https://coronavirus.jhu.edu/map.html. – reference: StefanNBirkenfeldALSchulzeMBGlobal pandemics interconnected—obesity, impaired metabolic health and COVID-19Nat Rev Endocrinol202117135491:CAS:528:DC%2BB3MXit1yqt7o%3D3347953810.1038/s41574-020-00462-1 – reference: GoldsmithCSTattiKMKsiazekTGRollinPEComerJALeeWWUltrastructural characterization of SARS coronavirusEmerg Infect Dis200410320615030705332293410.3201/eid1002.030913 – reference: ReitererMRajanMGomez-BanoyNLauJDGomez-EscobarLGMaLHyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2Cell Metab202133217488 e51:CAS:528:DC%2BB3MXitFCrs7jM34599884844333510.1016/j.cmet.2021.09.009 – reference: GiordanoACesariPCapparucciaLCastellucciMCintiSSema3A and neuropilin-1 expression and distribution in rat white adipose tissueJ Neurocytol200332345521:CAS:528:DC%2BD2cXisVehtg%3D%3D1472437710.1023/B:NEUR.0000011328.61376.bb – reference: Colleluori G, Graciotti L, Pesaresi M, Di Vincenzo A, Perugini J, Di Mercurio E, et al. Visceral fat inflammation and fat embolism are associated with lung’s lipidic hyaline membranes in COVID-19 patients. bioRxiv. 2021. https://doi.org/10.1101/2021.10.30.466586. – reference: LockeAEKahaliBBerndtSIJusticeAEPersTHDayFRGenetic studies of body mass index yield new insights for obesity biologyNature.20155181972061:CAS:528:DC%2BC2MXislehtL8%3D25673413438221110.1038/nature14177 – reference: WilliamsonEJWalkerAJBhaskaranKBaconSBatesCMortonCEFactors associated with COVID-19-related death using OpenSAFELYNature.202058443061:CAS:528:DC%2BB3cXhsFegtbzK32640463761107410.1038/s41586-020-2521-4 – reference: MuranoIBarbatelliGParisaniVLatiniCMuzzonigroGCastellucciMDead adipocytes, detected as crown-like structures, are prevalent in visceral fat depots of genetically obese miceJ Lipid Res200849156281:CAS:528:DC%2BD1cXotVOqu7Y%3D1839048710.1194/jlr.M800019-JLR200 – reference: Cantuti-CastelvetriLOjhaRPedroLDDjannatianMFranzJKuivanenSNeuropilin-1 facilitates SARS-CoV-2 cell entry and infectivityScience.2020370856601:CAS:528:DC%2BB3cXitlCmt7rF33082293785739110.1126/science.abd2985 – reference: Alessandrini F, Caucci S, Onofri V, Melchionda F, Tagliabracci A, Bagnarelli P, et al. Evaluation of the ion AmpliSeq SARS-CoV-2 research panel by massive parallel sequencing. Genes. 2020;11:929–941. – reference: CintiSZingarettiMCCancelloRCeresiEFerraraPMorphologic techniques for the study of brown adipose tissue and white adipose tissueMethods Mol Biol200115521511:STN:280:DC%2BD3MrlvVyrtg%3D%3D11293073 – volume: 155 start-page: 21 year: 2001 ident: 1071_CR47 publication-title: Methods Mol Biol – volume: 8 start-page: 420 year: 2020 ident: 1071_CR5 publication-title: Lancet Respir Med doi: 10.1016/S2213-2600(20)30076-X – volume: 41 start-page: 131 year: 2020 ident: 1071_CR27 publication-title: Am J Forensic Med Pathol doi: 10.1097/PAF.0000000000000544 – volume: 70 start-page: 355 year: 2021 ident: 1071_CR17 publication-title: Morb Mortal Wkly Rep. doi: 10.15585/mmwr.mm7010e4 – volume: 32 start-page: 345 year: 2003 ident: 1071_CR40 publication-title: J Neurocytol doi: 10.1023/B:NEUR.0000011328.61376.bb – volume: 43 start-page: e129 year: 2020 ident: 1071_CR13 publication-title: Diabetes Care doi: 10.2337/dc20-1333 – volume: 12 start-page: 652765 year: 2021 ident: 1071_CR18 publication-title: Front Endocrinol doi: 10.3389/fendo.2021.652765 – volume: 2021 start-page: 5519812 year: 2021 ident: 1071_CR45 publication-title: Case Rep Crit Care – volume: 542 start-page: 177 year: 2017 ident: 1071_CR20 publication-title: Nature. doi: 10.1038/nature21363 – volume: 16 start-page: e0254872 year: 2021 ident: 1071_CR28 publication-title: PLoS ONE doi: 10.1371/journal.pone.0254872 – volume: 125 start-page: 992 year: 2016 ident: 1071_CR44 publication-title: Anesthesiology. doi: 10.1097/ALN.0000000000001334 – ident: 1071_CR1 – volume: 368 start-page: 356 year: 2020 ident: 1071_CR4 publication-title: Science. doi: 10.1126/science.368.6489.356 – volume: 10 start-page: 320 year: 2004 ident: 1071_CR30 publication-title: Emerg Infect Dis doi: 10.3201/eid1002.030913 – volume: 396 start-page: 320 year: 2020 ident: 1071_CR6 publication-title: Lancet. doi: 10.1016/S0140-6736(20)31305-2 – volume: 29 start-page: 20 year: 2021 ident: 1071_CR11 publication-title: Obesity doi: 10.1002/oby.23007 – volume: 295 start-page: R781 year: 2008 ident: 1071_CR22 publication-title: Am J Physiol Regul Integr Comp Physiol doi: 10.1152/ajpregu.00183.2008 – volume: 49 start-page: 1562 year: 2008 ident: 1071_CR25 publication-title: J Lipid Res doi: 10.1194/jlr.M800019-JLR200 – volume: 184 start-page: 1990 year: 2021 ident: 1071_CR7 publication-title: Cell. doi: 10.1016/j.cell.2021.03.005 – ident: 1071_CR31 – volume: 46 start-page: 2347 year: 2005 ident: 1071_CR19 publication-title: J Lipid Res doi: 10.1194/jlr.M500294-JLR200 – volume: 89 start-page: 135 year: 2021 ident: 1071_CR2 publication-title: Adv Respir Med doi: 10.5603/ARM.a2021.0036 – ident: 1071_CR36 doi: 10.1038/s41366-021-01016-9 – volume: 111 start-page: 154319 year: 2020 ident: 1071_CR14 publication-title: Metabolism. doi: 10.1016/j.metabol.2020.154319 – volume: 16 start-page: e9610 year: 2020 ident: 1071_CR38 publication-title: Mol Syst Biol doi: 10.15252/msb.20209610 – volume: 44 start-page: 2486 year: 2020 ident: 1071_CR41 publication-title: Int J Obes doi: 10.1038/s41366-020-00670-9 – ident: 1071_CR52 doi: 10.1101/2021.10.30.466586 – volume: 7 year: 2017 ident: 1071_CR26 publication-title: Sci Rep doi: 10.1038/s41598-017-08444-6 – volume: 33 start-page: 479 year: 2021 ident: 1071_CR16 publication-title: Cell Metab doi: 10.1016/j.cmet.2021.01.016 – volume: 11 start-page: 392 year: 2020 ident: 1071_CR35 publication-title: Front Immunol doi: 10.3389/fimmu.2020.00392 – volume: 94 start-page: 1749 year: 2013 ident: 1071_CR48 publication-title: J Gen Virol doi: 10.1099/vir.0.052910-0 – volume: 370 start-page: 856 year: 2020 ident: 1071_CR39 publication-title: Science. doi: 10.1126/science.abd2985 – volume: 395 start-page: 497 year: 2020 ident: 1071_CR3 publication-title: Lancet. doi: 10.1016/S0140-6736(20)30183-5 – volume: 584 start-page: 430 year: 2020 ident: 1071_CR10 publication-title: Nature. doi: 10.1038/s41586-020-2521-4 – volume: 33 start-page: 2147 year: 2020 ident: 1071_CR34 publication-title: Mod Pathol doi: 10.1038/s41379-020-00649-x – ident: 1071_CR24 doi: 10.2337/db20-1094 – volume: 87 start-page: 125 year: 2005 ident: 1071_CR50 publication-title: Biochimie. doi: 10.1016/j.biochi.2004.11.007 – volume: 7 start-page: 439 year: 2009 ident: 1071_CR33 publication-title: Nat Rev Microbiol doi: 10.1038/nrmicro2147 – ident: 1071_CR46 – volume: 518 start-page: 197 year: 2015 ident: 1071_CR12 publication-title: Nature. doi: 10.1038/nature14177 – volume: 110 start-page: 154317 year: 2020 ident: 1071_CR15 publication-title: Metabolism. doi: 10.1016/j.metabol.2020.154317 – volume: 54 start-page: 2423 year: 2013 ident: 1071_CR32 publication-title: J Lipid Res doi: 10.1194/jlr.M038638 – volume: 6 start-page: e0064721 year: 2021 ident: 1071_CR42 publication-title: mSphere. doi: 10.1128/mSphere.00647-21 – volume: 77 start-page: 570 year: 2020 ident: 1071_CR43 publication-title: Histopathology. doi: 10.1111/his.14180 – volume: 33 start-page: 2174 year: 2021 ident: 1071_CR29 publication-title: Cell Metab doi: 10.1016/j.cmet.2021.09.009 – ident: 1071_CR49 doi: 10.3390/genes11080929 – volume: 44 start-page: 1800 year: 2020 ident: 1071_CR23 publication-title: Int J Obes. doi: 10.1038/s41366-020-0624-5 – ident: 1071_CR51 doi: 10.1002/0471141755.ph1208s25 – volume: 17 start-page: 135 year: 2021 ident: 1071_CR8 publication-title: Nat Rev Endocrinol doi: 10.1038/s41574-020-00462-1 – volume: 155 start-page: 111561 year: 2021 ident: 1071_CR21 publication-title: Exp Gerontol doi: 10.1016/j.exger.2021.111561 – volume: 36 start-page: 109364 year: 2021 ident: 1071_CR37 publication-title: Cell Rep doi: 10.1016/j.celrep.2021.109364 – volume: 10 start-page: e019259 year: 2021 ident: 1071_CR9 publication-title: J Am Heart Assoc doi: 10.1161/JAHA.120.019259 |
SSID | ssj0005502 ssj0033214 |
Score | 2.4944859 |
Snippet | Background
Preliminary data suggested that fat embolism could explain the importance of visceral obesity as a critical determinant of coronavirus disease-2019... Preliminary data suggested that fat embolism could explain the importance of visceral obesity as a critical determinant of coronavirus disease-2019 (COVID-19).... BackgroundPreliminary data suggested that fat embolism could explain the importance of visceral obesity as a critical determinant of coronavirus disease-2019... Preliminary data suggested that fat embolism could explain the importance of visceral obesity as a critical determinant of coronavirus disease-2019... |
SourceID | pubmedcentral proquest pubmed crossref springer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1009 |
SubjectTerms | 14 14/28 14/63 38 38/77 692/699/2743/2037 692/699/2743/393 82/51 Adipocytes Adipose tissue Body size Cell viability Coronaviruses COVID-19 COVID-19 - complications COVID-19 Testing Embolism Embolism, Fat Embolisms Endothelial cells Endothelial Cells - metabolism Epidemiology Health Promotion and Disease Prevention Humans Hyalin - metabolism Inflammation Inflammation - metabolism Internal Medicine Intra-Abdominal Fat - metabolism Lipids Lung Lungs Macrophages Medicine Medicine & Public Health Membranes Metabolic Diseases Obesity Obesity - metabolism Pneumonia Public Health SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Viral diseases |
Title | Visceral fat inflammation and fat embolism are associated with lung’s lipidic hyaline membranes in subjects with COVID-19 |
URI | https://link.springer.com/article/10.1038/s41366-022-01071-w https://www.ncbi.nlm.nih.gov/pubmed/35082385 https://www.proquest.com/docview/2656442804 https://www.proquest.com/docview/2623325911 https://pubmed.ncbi.nlm.nih.gov/PMC8790008 |
Volume | 46 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9RAEB-0BfFF6vkVW8sK4ouGJtlkN_ckvWuPKvQUseXewmazoYFc7mxyFPHFf8N_z7_EmWRzx1nsSxKS3Xwwv8zMzifAGyFCmVNm7jAV3A1lmLpKcFy4iiBDBSXzlaZ85_OpOLsIP82imTW41TassueJLaPOFpps5EcBKh4h6spe-GH53aWuUeRdtS007sMulS6jkC45k5sQj8hb15Li1JGnr4qIUj-yGTQej49q5OSCYnEpSgFlrnuzLaVuqZ63Iyj_caO20mmyB4-sWsmOOxw8hnumGoBzUpiGvWW29mfJpn3p_QE8OLdO9QEMNqojDm7bntdP4OdlUWsyWLFcNQxxiNDp0hyZqrL2pJmni7Ko50xdG6YsnU3GyLbLSuQif379rllZLAt8FLv6oUilZXOchgLS1HhTVq9SMgTV3Zzx58uPJ64_fAoXk9Nv4zPXdmpwNZK3cVNkm7EJUpFT7FoQaKEULlRMFiqTSh6lCg-GnpfpQAZcSe1LLw9jo3PlBxLXyc9gp1pU5gUwI7IszhWe9HU45JQ5jADSXAsT5n4sHfB7yiTaljGnbhpl0rrTeZx01EyQmklLzeTGgXfrOcuuiMedow96gif2h66TDfwceL2-PCdKlBSVvFjRmABRFqH4cOB5h4_143hELs04ckBuIWc9gMp8b1-piqu23HcsqbFr7MD7HmOb1_r_V7y8-yv24WHQ4p1CNw9gp7lemVeoXjXpYfsP4TYe-4ewezwZjaa4H51Ov3z9C3SWJGU |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFD4anQS8ICi3wAAjAS8QLbGdSx8QgnVTy9aC0DbtLXMcR4uUXlhaVRMv_A3-BD-KX8I5ubQqE3vbW5TYiaPz2eezzw3gle_LIKXI3E7sC1sGMraVL3Dj6vMECUriKk3xzoOh3zuSn0-8kw343cTCkFtlsyaWC3Uy0XRGvs2ReEjkyo78MP1uU9Uosq42JTQqWOybiwVu2Yr3_S7K9zXne7uHOz27ripgaxzKzI5xioeGx35Kflaca18pJNUmkcrEgfBihRcdx0k0D7hQgXYDJ5Wh0alyeYB7OnzvDdiUArcyLdj8tDv8-m3lVOI5y-xVgmoANXkYkWd4dcyOI8LtAnWHT96_5BeBWt5erOvFS2T3ss_mP4bbUh_u3YU7NZFlHyvk3YMNM26D1c3MjL1hdbbRnA2bZP9tuDmozfhtaK_IKjYuC60X9-HHcVZoOiJjqZoxRD6CtQqsZGqclDfNKJ7kWTFi6twwVSPLJIxOk1mO69afn78KlmfTDD_Fzi4UkWg2wm6okk2BL2XFPKajp6Lqs_PluN-13c4DOLoWKT6E1ngyNo-BGT9JwlThTVfLjqBYZYSsFto3MnXDwAK3kUyk68TpVL8jj0oDvgijSpoRSjMqpRktLHi77DOt0oZc2XqrEXhULyFFtAK8BS-Xj0ckiZz8oCdzasMRZR4qLAseVfhYfk54ZEQNPQuCNeQsG1Bi8fUn4-ysTDAeBlRKNrTgXYOx1bD-_xdPrv6LF3Crdzg4iA76w_2ncJuX2CfH0S1ozc7n5hmSu1n8vJ5RDE6vexL_BXWmX6M |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtNAEB6VIlVcUAl_pgUWCbiAFXtt7zoHhFBD1FAaONAqN3e9XquWHCfUiaKKC6_Bq_A4PAkz_kkUKnrrzbJn7bXmm53ZnT-Al0L4MqXM3F4sPNuXfmwr4eHGVfAEDZTEVZrynY9H4vDE_zQOxlvwu82FobDKdk2sFupkqumMvMvR8PDRVnb8btqERXztD97PvtvUQYo8rW07jRoiR-Zyidu38t2wj7x-xfng47eDQ7vpMGBrnNbcjlHcQ8NjkVLMFedaKIUGtkl8ZWLpBbHCi57jJJpL7impXemkfmh0qlwucX-H770Ft5HSJRmTY7kOLwmcVR0rj7oBtRUZ0eIImuwdxwu7JWoRQXHAFCGB-t5ebmrIK2bv1ejNf1y4lWYc7MLdxqRlH2oM3oMtU3TA6mdmzl6zpu5ozkZt2f8O7Bw3Dv0OdNZmKxJXLdfL-_DjNCs1HZaxVM0ZygDCtk6xZKpIqptmEk_zrJwwdWGYajBmEkbnyizHFezPz18ly7NZhp9i55eKzGk2wWGonE2JL2XlIqZDqLIec_DldNi33d4DOLkRHj6E7WJamMfAjEiSMFV409V-z6OsZQSv9rQwfuqG0gK35UykmxLq1MkjjypXvhdGNTcj5GZUcTNaWvBmNWZWFxC5lnq_ZXjULCZltIa-BS9WjyfEiZwioqcLouGIsgBVlwWPanysPucF5E4NAwvkBnJWBFRifPNJkZ1XpcZDSU1lQwvethhbT-v_f_Hk-r94DjsoutHn4ehoD-7wCvoUQboP2_OLhXmKVt48flaJE4Ozm5bfv_e6YnM |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Visceral+fat+inflammation+and+fat+embolism+are+associated+with+lung%E2%80%99s+lipidic+hyaline+membranes+in+subjects+with+COVID-19&rft.jtitle=International+Journal+of+Obesity+%282005%29&rft.au=Colleluori%2C+Georgia&rft.au=Graciotti%2C+Laura&rft.au=Pesaresi%2C+Mauro&rft.au=Di+Vincenzo%2C+Angelica&rft.date=2022-05-01&rft.pub=Nature+Publishing+Group+UK&rft.issn=0307-0565&rft.eissn=1476-5497&rft.volume=46&rft.issue=5&rft.spage=1009&rft.epage=1017&rft_id=info:doi/10.1038%2Fs41366-022-01071-w&rft_id=info%3Apmid%2F35082385&rft.externalDocID=PMC8790008 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0307-0565&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0307-0565&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0307-0565&client=summon |